Literature DB >> 1993749

Laboratory investigations on the low pathogenic potential of Plesiomonas shigelloides.

S L Abbott1, R P Kokka, J M Janda.   

Abstract

The pathogenic properties of 16 Plesiomonas shigelloides strains recovered from humans with extraintestinal and intestinal illnesses, infected animals, and environmental sources were investigated. Most strains possessed a high cell charge and low surface hydrophobicity analogous to those of Shigella spp.; additionally, serogroup O:17 strains reacted with Shigella group D antisera. However, unlike the shigellae, P. shigelloides strains did not universally bind Congo red, were noninvasive in HEp-2 cell assays, and did not produce a Shiga-like toxin on Vero cells. On HEp-2, Y1, and possibly Vero cells, a low-level cytolysin was consistently produced by all 16 P. shigelloides strains when grown in either Evan Casamino Acids-yeast extract or Penassay broth. The median 50% lethal dose for all 16 P. shigelloides strains in outbred Swiss Webster mice was 3.5 x 10(8) CFU (range, 3.2 x 10(7) to greater than 1 x 10(9) CFU). Animal pathogenicity did not correlate with cytolysin expression, possession of a greater than or equal to 120-MDa plasmid, protein profile, or resistance to complement-mediated lysis. No strain analyzed produced siderophores or a heat-stable enterotoxin. The results suggest that members of the genus Plesiomonas have an overall low pathogenic potential, irrespective of the site of isolation or phenotypic, serologic, or surface properties shared with other traditional enteropathogens.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993749      PMCID: PMC269719          DOI: 10.1128/jcm.29.1.148-153.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Universal chemical assay for the detection and determination of siderophores.

Authors:  B Schwyn; J B Neilands
Journal:  Anal Biochem       Date:  1987-01       Impact factor: 3.365

2.  Ionic, hydrophobic, and hemagglutinating properties of Shigella species.

Authors:  S Kabir; S Ali; Q Akhtar
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

Review 3.  Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

Authors:  P W Taylor
Journal:  Microbiol Rev       Date:  1983-03

4.  New O and H antigens and additional serovars of Plesiomonas shigelloides.

Authors:  T Shimada; R Sakazaki
Journal:  Jpn J Med Sci Biol       Date:  1985-04

5.  Invasive ability of Plesiomonas shigelloides.

Authors:  M M Binns; S Vaughan; S C Sanyal; K N Timmis
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1984-08

6.  Test for Escherichia coli enterotoxin using infant mice: application in a study of diarrhea in children in Honolulu.

Authors:  A G Dean; Y C Ching; R G Williams; L B Harden
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

7.  In vitro and in vivo pathogenicity of Plesiomonas shigelloides.

Authors:  D A Herrington; S Tzipori; R M Robins-Browne; B D Tall; M M Levine
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

8.  In vitro production of cholera toxin-like activity by Plesiomonas shigelloides.

Authors:  S E Gardner; S E Fowlston; W L George
Journal:  J Infect Dis       Date:  1987-11       Impact factor: 5.226

9.  Vibrio cholerae enterotoxin genes: nucleotide sequence analysis of DNA encoding ADP-ribosyltransferase.

Authors:  H A Lockman; J E Galen; J B Kaper
Journal:  J Bacteriol       Date:  1984-09       Impact factor: 3.490

10.  Plesiomonas shigelloides in acute cholecystitis: a case report.

Authors:  B E Claesson; D E Holmlund; C A Lindhagen; T W Mätzsch
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

View more
  10 in total

1.  New O and H antigens of the international antigenic scheme for Plesiomonas shigelloides.

Authors:  E Aldová; T Shimada
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

2.  Expression of hemolytic activity by Plesiomonas shigelloides.

Authors:  J M Janda; S L Abbott
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

3.  Plesiomonas shigelloides enters polarized human intestinal Caco-2 cells in an in vitro model system.

Authors:  C Theodoropoulos; T H Wong; M O'Brien; D Stenzel
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 4.  Plesiomonas shigelloides Revisited.

Authors:  J Michael Janda; Sharon L Abbott; Christopher J McIver
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

5.  Structural and pathogenic properties of Aeromonas schubertii.

Authors:  R P Kokka; D Lindquist; S L Abbott; J M Janda
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

6.  Phenotypic characterization and putative virulence factors of human, animal and environmental isolates of Plesiomonas shigelloides.

Authors:  A Salerno; I Cižnár; K Krovacek; M Conte; S Dumontet; C González-Rey; V Pasquale
Journal:  Folia Microbiol (Praha)       Date:  2011-01-21       Impact factor: 2.099

7.  Glucose tolerance and left ventricular pressure-volume relationships in frequently used mouse strains.

Authors:  Wouter Oosterlinck; Annelies Vanderper; Willem Flameng; Paul Herijgers
Journal:  J Biomed Biotechnol       Date:  2011-01-20

8.  Pathogenic properties of Edwardsiella species.

Authors:  J M Janda; S L Abbott; S Kroske-Bystrom; W K Cheung; C Powers; R P Kokka; K Tamura
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

9.  Iron uptake in Plesiomonas shigelloides: cloning of the genes for the heme-iron uptake system.

Authors:  P A Daskaleros; J A Stoebner; S M Payne
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

10.  Plesiomonas shigelloides infection, Ecuador, 2004-2008.

Authors:  Juan C Escobar; Darlene Bhavnani; Gabriel Trueba; Karina Ponce; William Cevallos; Joseph Eisenberg
Journal:  Emerg Infect Dis       Date:  2012-02       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.